Every weekday for over three decades, Morning Edition has taken listeners around the country and the world with two hours of multi-faceted stories and commentaries that inform, challenge and occasionally amuse.
https://www.kuow.org/podcasts/morning-edition
Novavax Vaccine Appears 86% Effective Against U.K's COVID-19 Variant
Vaccine maker Novavax is waiting for its COVID-19 vaccine to be approved in the U.K., and is hopeful that U.S. approval will follow. NPR's Steve Inskeep speaks to Novavax CEO Stanley Erck.